| Reference | FOI 2026/1650 |
|---|---|
| Description | GMMG CMPA guidance |
| Date Requested | 11/03/2026 |
| Date Replied | 24/03/2026 |
| Category | Medicines Optimisation |
I wished to enquire about the expired GMMG CMPA guidance.
When this is being renewed, who will be involved in the group reviewing and rewriting guidance and timescales.
I write in response to your Freedom of Information request, received by NHS Greater Manchester today.
In line with the Freedom of Information Act, section 45 Code of Practice, paragraphs 2.8 and 2.9, to be able to process your request and provide you with the correct information, I would be grateful if you could clarify the following:
I am sorry we are unable to help you currently, and I look forward to receiving your response, so that we can action your request.
It is these guidelines that have long expired – I appreciate it may be different now with ICB changes etc since 2020. GMMMG CMPA Guidance as you refer to.
The aim is to ensure that the updated guidance reflects current clinical practice and local commissioning arrangements.